We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,081

Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 - Part 3: Part D Drug Management Programs Following Adoption of the Comprehensive Addiction and Recovery Act
  • Epstein Becker Green
  • USA
  • January 3 2018

On November 28, 2017, the Centers for Medicare & Medicaid Services ("CMS") issued a proposed rule titled "Medicare Program; Contract Year 2019 Policy


Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 - Part 2: Beneficiary Cost, Access, and Protection
  • Epstein Becker Green
  • USA
  • January 3 2018

On November 28, 2017, the Centers for Medicare & Medicaid Services ("CMS") issued a proposed rule titled "Medicare Program; Contract Year 2019 Policy


Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 - Part 1: Negotiated Prices for Drugs
  • Epstein Becker Green
  • USA
  • January 3 2018

The Centers for Medicare & Medicaid Services ("CMS") issued a proposed rule titled "Medicare Program; Contract Year 2019 Policy and Technical Changes


Holidays Come Early as CMS Proposes to Significantly Narrow Training Requirements Under Medicare Advantage and Part D Plan Compliance Programs
  • Reed Smith LLP
  • USA
  • December 12 2017

A recent Centers for Medicare & Medicaid Services (CMS) proposed rule1 (the Proposed Rule) would mark the end of a heavily criticized and frequently


Proposed Medicare Advantage and Part D Regulations for CY 2019 - CMS Takes on the Opioid Epidemic
  • Mintz Levin
  • USA
  • December 5 2017

Americans today are facing an opioid epidemic that stems in part from the misuse of prescription drugs. CMS takes aim at this crisis in its CY 2019


CMS's Proposed Rule for Contract Year 2019 Is a Mixed Bag for Medicare Advantage Organizations and Prescription Drug Plan Sponsors
  • Crowell & Moring LLP
  • USA
  • November 30 2017

On November 28, 2017, CMS issued a notice of a proposed rulemaking for contract year 2019 policy and technical changes for the Medicare Advantage and


Proposed Medicare Advantage and Part D Regulations for CY 2019 - CMS Tries to Clarify Any Willing Pharmacy Rules
  • Mintz Levin
  • USA
  • November 29 2017

Medicare Part D plan sponsors and pharmacies are often confused by the program’s any willing pharmacy (AWP) requirements. Since the inception of the


CMS Proposes Key Changes to the Medicare Advantage Program
  • Hogan Lovells
  • USA
  • November 27 2017

On November 16, 2017, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule that would revise regulations and clarify


ML Strategies December 2017
  • Mintz Levin
  • USA
  • November 27 2017

The culmination of the year's legislative activity all comes down to the month of December so buckle up. Congress will need to pass a government


CMS Proposes Changes to Medicare Advantage, Part D Programs for 2019
  • Reed Smith LLP
  • USA
  • November 27 2017

CMS has issued a proposed rule to update the Medicare Advantage (MA) program and Part D prescription drug benefit rules for contract year 2019. The